In this report, we present a case of an elderly patient diagnosed with programmed death-ligand 1 (PD-L1) high-expression squamous non-small cell lung cancer (tumor proportion score [TPS] ≥ 50%) who had previously developed resistance to PD-1 monoclonal antibody therapy. This evidence concerns the gene CD274 and neoplasm.